agilon health Management
Management criteria checks 3/4
agilon health's CEO is Steve Sell, appointed in Jun 2020, has a tenure of 4.58 years. total yearly compensation is $5.27M, comprised of 14.2% salary and 85.8% bonuses, including company stock and options. directly owns 0.022% of the company’s shares, worth $170.58K. The average tenure of the management team and the board of directors is 3.3 years and 6.3 years respectively.
Key information
Steve Sell
Chief executive officer
US$5.3m
Total compensation
| CEO salary percentage | 14.2% |
| CEO tenure | 4.6yrs |
| CEO ownership | 0.02% |
| Management average tenure | 3.3yrs |
| Board average tenure | 6.3yrs |
Recent management updates
Recent updates
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Nov 10
agilon health Plunges On A Poor Prognosis (Rating Downgrade)
Nov 08Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Oct 15agilon health: Interesting Business Model, But Volatile And Uncertain
Aug 16Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower
Aug 16Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt
Jul 15The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More
Jun 06agilon health: Still Not Healthy Enough To Warrant Upside
Apr 19Is agilon health (NYSE:AGL) Using Too Much Debt?
Apr 04agilon health: High Growth But Unsustainable Economics
Nov 20agilon health: Strong Sales Growth, Lacks Remaining Value Drivers
Sep 13Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues
Jul 17agilon health: A Hold Until Margins Are Improved
Jun 30An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued
Jun 06Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?
Apr 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$311m |
| Jun 30 2024 | n/a | n/a | -US$217m |
| Mar 31 2024 | n/a | n/a | -US$202m |
| Dec 31 2023 | US$5m | US$750k | -US$195m |
| Sep 30 2023 | n/a | n/a | -US$69m |
| Jun 30 2023 | n/a | n/a | -US$78m |
| Mar 31 2023 | n/a | n/a | -US$83m |
| Dec 31 2022 | US$6m | US$750k | -US$92m |
| Sep 30 2022 | n/a | n/a | -US$108m |
| Jun 30 2022 | n/a | n/a | -US$114m |
| Mar 31 2022 | n/a | n/a | -US$391m |
| Dec 31 2021 | US$1m | US$750k | -US$384m |
| Sep 30 2021 | n/a | n/a | -US$387m |
| Jun 30 2021 | n/a | n/a | -US$363m |
| Mar 31 2021 | n/a | n/a | -US$69m |
| Dec 31 2020 | US$6m | US$433k | -US$63m |
Compensation vs Market: Steve's total compensation ($USD5.27M) is above average for companies of similar size in the US market ($USD3.23M).
Compensation vs Earnings: Steve's compensation has been consistent with company performance over the past year.
CEO
Steve Sell (58 yo)
4.6yrs
Tenure
US$5,267,036
Compensation
Mr. Steven Jackson Sell, also known as Steve, has been President and Chief Executive Officer at Agilon Health, Inc. since June 1, 2020 and also has been its Director since June 2020. Mr. Sell also serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.6yrs | US$5.27m | 0.022% $ 170.6k | |
| Executive VP & CFO | less than a year | US$230.00k | 0.0077% $ 60.7k | |
| Chief Technology Officer | 4yrs | US$2.88m | 0.0033% $ 25.9k | |
| Chief Markets Officer | 4.3yrs | US$2.93m | 0.055% $ 430.5k | |
| VP, Controller & Chief Accounting Officer | 2.8yrs | no data | 0.014% $ 110.1k | |
| Senior Manager of Investor Relations | no data | no data | no data | |
| Chief Legal Officer & Secretary | 2.4yrs | no data | no data | |
| Chief Communications & Public Affairs Officer | 3.4yrs | no data | no data | |
| Chief People Officer | 3.3yrs | no data | no data | |
| Chief of Technology Innovation | no data | no data | no data | |
| Markets Chief Financial Officer | no data | no data | no data | |
| Chief Clinical Officer | less than a year | no data | no data |
3.3yrs
Average Tenure
48yo
Average Age
Experienced Management: AGL's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.6yrs | US$5.27m | 0.022% $ 170.6k | |
| Chairman of the Board | 8yrs | US$160.00k | 0.87% $ 6.8m | |
| Vice Chairman of the Board | 8yrs | no data | no data | |
| Independent Director | 8yrs | US$245.00k | 0.30% $ 2.4m | |
| Independent Director | 1.6yrs | US$374.85k | 0.0083% $ 64.7k | |
| Independent Director | 1.9yrs | US$405.44k | 0.0065% $ 50.7k | |
| Independent Director | 3.5yrs | US$292.50k | 0.010% $ 78.0k | |
| Independent Director | 8yrs | US$230.00k | 0.042% $ 330.6k |
6.3yrs
Average Tenure
58.5yo
Average Age
Experienced Board: AGL's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 11:58 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
agilon health, inc. is covered by 29 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Andrew Mok | Barclays |
| William Sutherland | Benchmark Company |